Invesco Biotechnology & Genome ETF
PBE
PBE
103 hedge funds and large institutions have $77.6M invested in Invesco Biotechnology & Genome ETF in 2022 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 14 increasing their positions, 28 reducing their positions, and 3 closing their positions.
Holders
103
Holders Change
+17
Holders Change %
+19.77%
% of All Funds
1.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
14
Reduced
28
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
![]()
1
JPMorgan Chase & Co
New York
|
$1.77M |
2 |
2
Morgan Stanley
New York
|
$13.3M |
3 |
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$1.08M |
4 |
4
Goldman Sachs
New York
|
$471K |
5 |
5
Cetera Investment Advisers
Schaumburg,
Illinois
|
$349K |